找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Vascular Embolotherapy; A Comprehensive Appr Jafar Golzarian (Professor of Radiology, Departmen Book 2006 Springer-Verlag Berlin Heidelberg

[復(fù)制鏈接]
樓主: Menthol
11#
發(fā)表于 2025-3-23 11:13:20 | 只看該作者
12#
發(fā)表于 2025-3-23 16:15:17 | 只看該作者
Yttrium-90 Radioembolization for the Treatment of Liver Metastasesaforementioned studies representing the collective clinical experience supporting the safety and therapeutic benefit of TheraSphere and SIR-Spheres in patients with metastatic disease to the liver suggest further investigation for additional applications. Disease states where further work should be
13#
發(fā)表于 2025-3-23 18:18:23 | 只看該作者
Portal Vein Embolizationher than proximal occlusion or ligation. Embolic agents producing high local inflammatory reaction induce greater hypertrophy than others do..PVE neither improves nor worsens long-term prognosis but it allows curative resection in patients that otherwise are considered as unresectable. Nowadays, it
14#
發(fā)表于 2025-3-23 23:11:49 | 只看該作者
Embolotherapy for Neuroendocrine Tumor Hepatic Metastasesing small numbers of patients. It is unlikely that this situation will change in the near future, since prospective studies are difficult to perform in such a relatively rare and biologically heterogeneous disease. Embolotherapy is a widely accepted method of treatment for nonresectable hepatic meta
15#
發(fā)表于 2025-3-24 06:26:31 | 只看該作者
16#
發(fā)表于 2025-3-24 09:46:47 | 只看該作者
17#
發(fā)表于 2025-3-24 14:06:08 | 只看該作者
Endovenous Thermal Ablation of Incompetent Truncal Veins in Patients with Superficial Venous Insuffient SVI due to a virtual absence of the high rate of groin neovascularity seen with high ligation and stripping of the GSV. EVTA procedures have already begun to supplant traditional surgery for truncal incompetence.
18#
發(fā)表于 2025-3-24 15:00:11 | 只看該作者
19#
發(fā)表于 2025-3-24 19:28:02 | 只看該作者
20#
發(fā)表于 2025-3-25 01:14:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 17:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
交口县| 宝丰县| 江油市| 柳林县| 大同市| 五指山市| 龙岩市| 中方县| 昂仁县| 百色市| 萝北县| 天津市| 旬阳县| 桐庐县| 乐都县| 大冶市| 鲜城| 佛冈县| 莱西市| 济南市| 昭通市| 嘉荫县| 潮州市| 泽普县| 图们市| 镇康县| 博客| 三都| 突泉县| 濮阳县| 扎囊县| 民丰县| 方山县| 霞浦县| 亳州市| 洪湖市| 银川市| 新巴尔虎右旗| 新闻| 辽阳县| 宁都县|